Moreover, several additional co-inhibitory receptor–ligand interactions, aside from the PD-1/PD-L1 axis, have been described, which can either directly or indirectly suppress the anti-tumor function of CD8+ T cells in the tumor microenvironment. Here, CD274 is linked to neoplasm.